Northfield Laboratories, Inc.


Nov 11, 02

18:58 ET Northfield Laboratories Receives FDA Response on Proposed Ambulance Trail

 
Oct 16, 02

07:55 ET Northfield Laboratories Proposes First Ambulance Blood Substitute Trial

 
07:03 ET Northfield Laboratories Reports First-Quarter Results

 
Oct 09, 02

17:20 ET Northfield Laboratories Sets Date and Time for First Quarterly Conference Call

 
Oct 08, 02

16:31 ET Leading Trauma Surgeon Declares 'The Future Is Now' for Blood Substitutes

 
Oct 04, 02

12:05 ET Northfield Laboratories Collaborates With U.S. Army on PolyHeme(TM) Treatment IND

 
Oct 03, 02

16:20 ET Northfield Announces Certification of Annual Meeting Results

 
Sep 30, 02

16:00 ET Northfield Updates Shareholders Regarding Final Annual Meeting Results

 
Sep 27, 02

08:30 ET PolyHeme Data Presented at the 62nd Annual Meeting of the American Association For the Surgery of Trauma

 
Sep 24, 02

11:07 ET Northfield Announces Delay In Finalizing Annual Meeting Results

 
Sep 17, 02

16:10 ET Northfield Announces Annual Meeting Voting Results

 
Sep 13, 02

18:02 ET Northfield Announces Preliminary Results Of Board Elections

 
Sep 12, 02

17:26 ET Webcast Alert: Northfield Laboratories Inc. Announces 2002 Annual Meeting Of Stockholders Webcast Friday September 13, 2002 at 11:00 am EDT

 
14:48 ET Northfield Encourages Shareholders To Participate In Annual Meeting

 
09:34 ET Northfield Responds to False Accusations by C. Robert Coates

 
Sep 04, 02

12:00 ET Northfield to Webcast Annual Meeting Live

 
Aug 30, 02

12:50 ET Northfield CEO Sends Letter to Shareholders

 
11:47 ET Northfield Responds to Claims of Dissident Shareholder

 
Aug 29, 02

12:06 ET Northfield Builds Support for PolyHeme in Medical and Scientific Communities

 
Aug 22, 02

16:50 ET Northfield Questions Credibility Of Dissident Director Nominees

 
Aug 09, 02

16:07 ET Northfield Laboratories Urges Shareholders to Review Proxy Materials And Return Blue Proxy Cards Immediately

 
Aug 01, 02

18:20 ET Northfield Laboratories Urges Caution Regarding Dissident Shareholder

 
Jul 24, 02

15:40 ET Northfield Laboratories Announces Board and Management Changes

 
Jul 11, 02

15:37 ET Northfield Laboratories Receives Director Nominations

 
Jun 05, 02

12:43 ET Northfield Laboratories Trauma Data to Be Published by The Journal of The American College Of Surgeons

 
May 15, 02

15:35 ET Northfield Laboratories Comments on Stock Activity

 
May 09, 02

12:00 ET Northfield Laboratories Presents at Deutsche Banc Alex. Brown Healthcare Conference

 
May 07, 02

18:38 ET Northfield Laboratories To Present At Deutsche Banc Alex. Brown Healthcare Conference

 
Apr 15, 02

08:33 ET Northfield Laboratories Reports Fiscal 2002 Third Quarter Results

 
Jan 11, 02

18:08 ET Northfield Laboratories Reports Fiscal 2002 Second Quarter Results

 
Dec 21, 01

08:30 ET Northfield Laboratories to Schedule Meeting With FDA to Discuss Application

 
Nov 19, 01

18:54 ET Northfield Labs Receives FDA Comments on Application For Blood Substitute

 
Oct 16, 01

14:59 ET Northfield Laboratories Reports Fiscal 2002 First Quarter Results

 
Oct 11, 01

14:20 ET Northfield Labs Trauma Data Establish PolyHeme's Remarkable Life-Sustaining Capacity as Blood Substitute

 
Sep 04, 01

07:31 ET Northfield Discusses Strength of Data and FDA Application

 
Aug 28, 01

13:17 ET Northfield Laboratories Submits Biologics License Application to FDA For Approval of Its Blood Substitute, PolyHeme(TM)

 
08:30 ET Northfield Laboratories Invites You to Listen to Its Annual Business Update On The Web

 
Aug 20, 01

15:41 ET Northfield Confirms Annual Meeting Date as August 31; Lawsuit to Postpone Meeting Dismissed

 
Aug 17, 01

13:32 ET Northfield Laboratories Sees No Merit in Suit to Postpone Annual Meeting

 
Aug 16, 01

13:02 ET Northfield Intends to Submit FDA Application Before Labor Day; Data Analysis For Application Complete

 
Aug 03, 01

17:46 ET Northfield Laboratories Reports Fiscal 2001 Results; Annual Meeting Set For Late August

 
May 11, 01

08:30 ET Northfield Laboratories Discussed Regulatory Statusa and Product Advantages At Deutsche Banc Alex. Brown Healthcare Conference

 
May 08, 01

17:45 ET Northfield Laboratories to Webcast Presentation at Deutsche Banc Alex Brown Healthcare Conference

 
Apr 17, 01

08:15 ET Northfield Laboratories Reports Fiscal 2001 Third Quarter Results

 
Jan 12, 01

16:01 ET Northfield Laboratories Reports Fiscal 2001 Second Quarter Results

 
Nov 07, 00

17:29 ET Northfield Laboratories Presents Business and Clinical Updates At Investor and Scientific Forums

 
Oct 18, 00

18:26 ET Northfield Laboratories Reports Fiscal 2001 First Quarter Results

 
Oct 12, 00

17:24 ET Northfield Laboratories' Management Enthusiastic About Future Prospects

 
Oct 09, 00

17:30 ET Northfield Laboratories 2000 Annual Meeting This Week; Business Update Accessible Online

 
Sep 26, 00

19:21 ET Northfield Labs and C. Robert Coates and Management Insights Reach Agreement

 
Aug 25, 00

10:00 ET Northfield Laboratories Reports Fiscal 2000 Results; To Host Annual Meeting Online

 
Jul 28, 00

17:45 ET Northfield Laboratories Sets Annual Meeting Date

 
Apr 18, 00

12:31 ET Northfield Laboratories Reports Fiscal 2000 Third Quarter Results

 
Jan 14, 00

18:43 ET Northfield Laboratories Reports Fiscal 2000 Second Quarter Results

 
Oct 20, 99

18:04 ET Northfield Laboratories Reports Results for First Quarter

 
Aug 30, 99

12:44 ET Northfield Laboratories Reports Fiscal 1999 Results

 
May 04, 99

18:17 ET Northfield Labs Reports Results of Blood Substitute Research; Tells HHS Committee Polyheme Improves Survival in Trauma

 
Apr 29, 99

17:15 ET Northfield Labs to Present Results to Health and Human Services Committee On Blood Safety and Availability

 
Apr 15, 99

17:15 ET Northfield Laboratories Reports Fiscal 1999 Third Quarter Results

 
Oct 19, 98

17:00 ET Northfield Laboratories Reports Results for First Quarter

 
Sep 02, 98

11:05 ET Northfield Laboratories Reports Fiscal 1998 and Fourth Quarter Results

 
Aug 12, 98

08:54 ET Northfield Asked to Expand Patient Numbers in Phase III Trials in Elective Surgery;

 
May 12, 98

13:32 ET Northfield Laboratories to Start European Trials of Blood Substitute With Pharmacia & Upjohn AB

 
May 08, 98

18:27 ET Northfield Laboratories Names David A. Savner Director

 
Jan 21, 98

16:30 ET Northfield Laboratories Reports Second Quarter Results; Phase III Trials of Blood Substitute Continue

 
Oct 16, 97

14:15 ET Northfield Reports Clinical Success to the American College of Surgeons

 
Oct 15, 97

18:04 ET Northfield Laboratories Reports Results For First Quarter

 
Sep 04, 97

14:48 ET Northfield Laboratories Initiates Phase III Trials of Blood Substitute; Reports Results for Fiscal Year

 
May 06, 97

14:36 ET Northfield Laboratories Enters Home Stretch For Blood Substitute Product

 
Apr 16, 97

17:34 ET Northfield Laboratories Reports Results For Third Quarter

 
Apr 02, 97

12:26 ET Northfield Laboratories Cleared For Phase III Blood Substitute Trials; First To Enter Phase III At Large Doses

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2005 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.